

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.25918601 |
| 2 | exogenous drug catabolic process (GO:0042738) | 8.18476926 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.55881002 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.55881002 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 7.30972666 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.20235579 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.20235579 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.78415918 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.40095012 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.07866568 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.07866568 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.07866568 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.99321261 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.96082969 |
| 15 | opsonization (GO:0008228) | 5.82128593 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.78948648 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.74150590 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.74125747 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.72730601 |
| 20 | urea cycle (GO:0000050) | 5.69840281 |
| 21 | urea metabolic process (GO:0019627) | 5.69840281 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.61441357 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.52441740 |
| 24 | protein carboxylation (GO:0018214) | 5.43894611 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.43894611 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.42139663 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.40564839 |
| 28 | cysteine metabolic process (GO:0006534) | 5.36272039 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.34627747 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.22980383 |
| 31 | mesodermal cell differentiation (GO:0048333) | 5.18450949 |
| 32 | bile acid metabolic process (GO:0008206) | 5.13592471 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.11751533 |
| 34 | regulation of complement activation (GO:0030449) | 5.03011335 |
| 35 | regulation of plasminogen activation (GO:0010755) | 5.02371945 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.91986626 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.91231498 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 4.89898214 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86627173 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.83450544 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.83450544 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.83450544 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.83367552 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.82054175 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.81748588 |
| 46 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.75618640 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.66227500 |
| 48 | drug metabolic process (GO:0017144) | 4.65370797 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.62424916 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.62424916 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.62340439 |
| 52 | endocardial cushion development (GO:0003197) | 4.61083846 |
| 53 | respiratory tube development (GO:0030323) | 4.59996692 |
| 54 | phospholipid efflux (GO:0033700) | 4.59790565 |
| 55 | lysine catabolic process (GO:0006554) | 4.59151650 |
| 56 | lysine metabolic process (GO:0006553) | 4.59151650 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.58594309 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.58594309 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 4.56296418 |
| 60 | midgut development (GO:0007494) | 4.53856499 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.48017453 |
| 62 | glycine metabolic process (GO:0006544) | 4.46830761 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 4.44311434 |
| 64 | negative regulation of blood coagulation (GO:0030195) | 4.38926260 |
| 65 | negative regulation of hemostasis (GO:1900047) | 4.38926260 |
| 66 | oxidative demethylation (GO:0070989) | 4.37720306 |
| 67 | cellular glucuronidation (GO:0052695) | 4.34525496 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.32667399 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.31261702 |
| 70 | cholesterol efflux (GO:0033344) | 4.28762989 |
| 71 | coenzyme catabolic process (GO:0009109) | 4.28641772 |
| 72 | lung vasculature development (GO:0060426) | 4.25377041 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.24955812 |
| 74 | glutamate metabolic process (GO:0006536) | 4.21656582 |
| 75 | amine catabolic process (GO:0009310) | 4.20044727 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 4.20044727 |
| 77 | serine family amino acid metabolic process (GO:0009069) | 4.17894587 |
| 78 | low-density lipoprotein particle remodeling (GO:0034374) | 4.14704118 |
| 79 | negative regulation of coagulation (GO:0050819) | 4.09906806 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 4.09529657 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.08089398 |
| 82 | serine family amino acid biosynthetic process (GO:0009070) | 4.06712716 |
| 83 | fibrinolysis (GO:0042730) | 4.06114948 |
| 84 | negative regulation of wound healing (GO:0061045) | 4.06074411 |
| 85 | ethanol oxidation (GO:0006069) | 4.05506898 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05306957 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 4.01803859 |
| 88 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.01293638 |
| 89 | arginine metabolic process (GO:0006525) | 3.99214933 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.98053036 |
| 91 | ketone body metabolic process (GO:1902224) | 3.94785397 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.94181651 |
| 93 | cell adhesion mediated by integrin (GO:0033627) | 3.89447347 |
| 94 | positive regulation of blood coagulation (GO:0030194) | 3.89173418 |
| 95 | positive regulation of hemostasis (GO:1900048) | 3.89173418 |
| 96 | drug catabolic process (GO:0042737) | 3.88828552 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.86580237 |
| 98 | uronic acid metabolic process (GO:0006063) | 3.84799304 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.84799304 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.84317968 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.82504327 |
| 102 | cholesterol homeostasis (GO:0042632) | 3.77846417 |
| 103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.77753598 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.77753598 |
| 105 | protein activation cascade (GO:0072376) | 3.77141254 |
| 106 | complement activation (GO:0006956) | 3.75820704 |
| 107 | cofactor catabolic process (GO:0051187) | 3.75186584 |
| 108 | complement activation, classical pathway (GO:0006958) | 3.74674824 |
| 109 | endodermal cell differentiation (GO:0035987) | 3.74453848 |
| 110 | negative regulation of lipase activity (GO:0060192) | 3.73267177 |
| 111 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.73224013 |
| 112 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.73224013 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.72860627 |
| 114 | organic acid catabolic process (GO:0016054) | 3.72860627 |
| 115 | sterol homeostasis (GO:0055092) | 3.71551367 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.69740573 |
| 117 | protein-lipid complex assembly (GO:0065005) | 3.68447142 |
| 118 | plasma lipoprotein particle organization (GO:0071827) | 3.68428951 |
| 119 | acetyl-CoA metabolic process (GO:0006084) | 3.63541861 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.61289736 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 3.60137616 |
| 122 | cytolysis (GO:0019835) | 3.59965937 |
| 123 | negative regulation of protein activation cascade (GO:2000258) | 3.58521995 |
| 124 | positive regulation of coagulation (GO:0050820) | 3.56340836 |
| 125 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.54510753 |
| 126 | acute-phase response (GO:0006953) | 3.54393299 |
| 127 | regulation of humoral immune response (GO:0002920) | 3.48611411 |
| 128 | lung lobe morphogenesis (GO:0060463) | 3.47165189 |
| 129 | ethanol metabolic process (GO:0006067) | 3.35807598 |
| 130 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.29362096 |
| 131 | regulation of blood coagulation (GO:0030193) | 3.11804905 |
| 132 | regulation of hemostasis (GO:1900046) | 3.11804905 |
| 133 | lung morphogenesis (GO:0060425) | 3.07589091 |
| 134 | virion attachment to host cell (GO:0019062) | 3.04698810 |
| 135 | adhesion of symbiont to host cell (GO:0044650) | 3.04698810 |
| 136 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.01687561 |
| 137 | negative regulation of complement activation (GO:0045916) | 2.97753939 |
| 138 | hyaluronan catabolic process (GO:0030214) | 2.93454298 |
| 139 | regulation of coagulation (GO:0050818) | 2.93300870 |
| 140 | regulation of apoptotic cell clearance (GO:2000425) | 2.92683304 |
| 141 | positive regulation of wound healing (GO:0090303) | 2.91663834 |
| 142 | bone trabecula formation (GO:0060346) | 2.90893364 |
| 143 | hormone catabolic process (GO:0042447) | 2.89399667 |
| 144 | skin morphogenesis (GO:0043589) | 2.88539626 |
| 145 | substrate-dependent cell migration (GO:0006929) | 2.85258163 |
| 146 | anterior/posterior axis specification, embryo (GO:0008595) | 2.84416908 |
| 147 | basement membrane organization (GO:0071711) | 2.82581130 |
| 148 | pericardium development (GO:0060039) | 2.81754754 |
| 149 | cellular response to vitamin (GO:0071295) | 2.79922781 |
| 150 | adhesion of symbiont to host (GO:0044406) | 2.76535460 |
| 151 | S-adenosylmethionine metabolic process (GO:0046500) | 2.76511154 |
| 152 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.74910378 |
| 153 | cellular response to vitamin D (GO:0071305) | 2.72787517 |
| 154 | phenylpropanoid metabolic process (GO:0009698) | 2.71924554 |
| 155 | flavonoid metabolic process (GO:0009812) | 2.69582904 |
| 156 | positive regulation of osteoblast proliferation (GO:0033690) | 2.68568272 |
| 157 | renal system process involved in regulation of blood volume (GO:0001977) | 2.63972743 |
| 158 | acute inflammatory response (GO:0002526) | 2.63425807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.42468867 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20537224 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.02974539 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.55500966 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.27763552 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24296241 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.11330427 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.77557850 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06505885 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.99946483 |
| 11 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.50170290 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.48248951 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.17798031 |
| 14 | TP53_18474530_ChIP-ChIP_U2OS_Human | 2.14823203 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07421436 |
| 16 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.02878125 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0117218 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98771054 |
| 19 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.97194053 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92577868 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.84509962 |
| 22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.82885293 |
| 23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.80689162 |
| 24 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.76872079 |
| 25 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.71756787 |
| 26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64937296 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63265924 |
| 28 | TP53_16413492_ChIP-PET_HCT116_Human | 1.60019406 |
| 29 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58402445 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47936696 |
| 31 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43300075 |
| 32 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41816001 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40469480 |
| 34 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35997228 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35648456 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24210105 |
| 37 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.23443999 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22982521 |
| 39 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.22326268 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21302344 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18010592 |
| 42 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16694388 |
| 43 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16115843 |
| 44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16108272 |
| 45 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14767555 |
| 46 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.13786415 |
| 47 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11129601 |
| 48 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11129601 |
| 49 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06767509 |
| 50 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06298086 |
| 51 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.05664396 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.05331427 |
| 53 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.05036278 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04188361 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.04076395 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01894167 |
| 57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00949955 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00651382 |
| 59 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.00429880 |
| 60 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.00429880 |
| 61 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99449270 |
| 62 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98670267 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97743610 |
| 64 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95258089 |
| 65 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95183179 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.95171061 |
| 67 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94840815 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93986705 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93602967 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93565288 |
| 71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93250582 |
| 72 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92921746 |
| 73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92799677 |
| 74 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92420579 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89392230 |
| 76 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.89056475 |
| 77 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87608568 |
| 78 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87287975 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86635045 |
| 80 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.84832680 |
| 81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84796963 |
| 82 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83989091 |
| 83 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83989091 |
| 84 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83483158 |
| 85 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83148780 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82940718 |
| 87 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.82928723 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82143806 |
| 89 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.80403891 |
| 90 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.80400664 |
| 91 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79993225 |
| 92 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.79908972 |
| 93 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.79527993 |
| 94 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.79245745 |
| 95 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78584509 |
| 96 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.78189044 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.76631655 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76503245 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76156712 |
| 100 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74967959 |
| 101 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73626964 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73293459 |
| 103 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.73248488 |
| 104 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73226187 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72952882 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.72741281 |
| 107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.72688959 |
| 108 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71545797 |
| 109 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69835019 |
| 110 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.67762990 |
| 111 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67272026 |
| 112 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67272026 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66182674 |
| 114 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61017297 |
| 115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.60170652 |
| 116 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60090077 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58599389 |
| 118 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57057764 |
| 119 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56568300 |
| 120 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.56413342 |
| 121 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56356564 |
| 122 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54629703 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54059028 |
| 124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53109805 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.51592255 |
| 126 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51049606 |
| 127 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50760309 |
| 128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50170977 |
| 129 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.50162727 |
| 130 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.49936180 |
| 131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49625951 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48787731 |
| 133 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48228175 |
| 134 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47707373 |
| 135 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47649256 |
| 136 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.47015205 |
| 137 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46860363 |
| 138 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.46187232 |
| 139 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45296178 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44981902 |
| 141 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.44906214 |
| 142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44590175 |
| 143 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44373328 |
| 144 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43685322 |
| 145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43513582 |
| 146 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43198397 |
| 147 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41969192 |
| 148 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.41619181 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41567575 |
| 150 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40666522 |
| 151 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.40582188 |
| 152 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40439371 |
| 153 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.39860645 |
| 154 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36633901 |
| 155 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36459682 |
| 156 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36386155 |
| 157 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36329985 |
| 158 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.36317308 |
| 159 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35629525 |
| 160 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.34450551 |
| 161 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34360051 |
| 162 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.33469170 |
| 163 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.33439514 |
| 164 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33133259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.34853003 |
| 2 | MP0005360_urolithiasis | 7.60374990 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.48613039 |
| 4 | MP0005365_abnormal_bile_salt | 6.14694315 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.11836295 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 4.68970242 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.28657213 |
| 8 | MP0003252_abnormal_bile_duct | 3.94783603 |
| 9 | MP0001986_abnormal_taste_sensitivity | 3.62679868 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.62168260 |
| 11 | MP0004272_abnormal_basement_membrane | 3.41711677 |
| 12 | MP0009840_abnormal_foam_cell | 3.23547512 |
| 13 | MP0005083_abnormal_biliary_tract | 3.20252164 |
| 14 | MP0003195_calcinosis | 2.77347834 |
| 15 | MP0005332_abnormal_amino_acid | 2.71301140 |
| 16 | MP0003279_aneurysm | 2.70656828 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.60326004 |
| 18 | MP0003283_abnormal_digestive_organ | 2.54246597 |
| 19 | MP0005257_abnormal_intraocular_pressure | 2.28389568 |
| 20 | MP0003566_abnormal_cell_adhesion | 2.26907441 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.24224506 |
| 22 | MP0000609_abnormal_liver_physiology | 2.17383779 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.13528831 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.08901148 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.93687127 |
| 26 | MP0003868_abnormal_feces_composition | 1.93330867 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.92991678 |
| 28 | MP0002295_abnormal_pulmonary_circulatio | 1.92962513 |
| 29 | MP0005623_abnormal_meninges_morphology | 1.91550754 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.80899428 |
| 31 | MP0001542_abnormal_bone_strength | 1.76542935 |
| 32 | MP0009697_abnormal_copulation | 1.67803312 |
| 33 | MP0001879_abnormal_lymphatic_vessel | 1.65122819 |
| 34 | MP0000767_abnormal_smooth_muscle | 1.64460759 |
| 35 | MP0001764_abnormal_homeostasis | 1.62421135 |
| 36 | MP0005023_abnormal_wound_healing | 1.59677127 |
| 37 | MP0005595_abnormal_vascular_smooth | 1.58304345 |
| 38 | MP0001958_emphysema | 1.58164829 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54823251 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.47956761 |
| 41 | MP0005275_abnormal_skin_tensile | 1.46274209 |
| 42 | MP0002282_abnormal_trachea_morphology | 1.42690776 |
| 43 | MP0001915_intracranial_hemorrhage | 1.42490942 |
| 44 | MP0005451_abnormal_body_composition | 1.40917057 |
| 45 | MP0003011_delayed_dark_adaptation | 1.34440711 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.34261237 |
| 47 | MP0003705_abnormal_hypodermis_morpholog | 1.32209398 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.31316269 |
| 49 | MP0003091_abnormal_cell_migration | 1.24172670 |
| 50 | MP0000534_abnormal_ureter_morphology | 1.22455238 |
| 51 | MP0003186_abnormal_redox_activity | 1.22222007 |
| 52 | MP0009643_abnormal_urine_homeostasis | 1.19728894 |
| 53 | MP0000598_abnormal_liver_morphology | 1.19180522 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.12377772 |
| 55 | MP0000858_altered_metastatic_potential | 1.12323984 |
| 56 | MP0005647_abnormal_sex_gland | 1.11460967 |
| 57 | MP0005187_abnormal_penis_morphology | 1.11007757 |
| 58 | MP0000751_myopathy | 1.09629490 |
| 59 | MP0003119_abnormal_digestive_system | 1.07184586 |
| 60 | MP0005197_abnormal_uvea_morphology | 1.06868938 |
| 61 | MP0010368_abnormal_lymphatic_system | 1.06126876 |
| 62 | MP0000604_amyloidosis | 1.05735822 |
| 63 | MP0003448_altered_tumor_morphology | 1.05225301 |
| 64 | MP0009764_decreased_sensitivity_to | 1.04065334 |
| 65 | MP0002896_abnormal_bone_mineralization | 1.03589725 |
| 66 | MP0009763_increased_sensitivity_to | 1.02509440 |
| 67 | MP0004134_abnormal_chest_morphology | 1.00951725 |
| 68 | MP0002254_reproductive_system_inflammat | 0.99243356 |
| 69 | MP0006054_spinal_hemorrhage | 0.98861263 |
| 70 | MP0003385_abnormal_body_wall | 0.97387995 |
| 71 | MP0003942_abnormal_urinary_system | 0.97054450 |
| 72 | MP0005508_abnormal_skeleton_morphology | 0.94488279 |
| 73 | MP0009250_abnormal_appendicular_skeleto | 0.93849587 |
| 74 | MP0002128_abnormal_blood_circulation | 0.93407324 |
| 75 | MP0000462_abnormal_digestive_system | 0.93029455 |
| 76 | MP0001299_abnormal_eye_distance/ | 0.92905578 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.90511555 |
| 78 | MP0005408_hypopigmentation | 0.88140139 |
| 79 | MP0009642_abnormal_blood_homeostasis | 0.85899411 |
| 80 | MP0008469_abnormal_protein_level | 0.85818387 |
| 81 | MP0005503_abnormal_tendon_morphology | 0.85108888 |
| 82 | MP0005376_homeostasis/metabolism_phenot | 0.78565811 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.77966662 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.77735756 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 0.76665408 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 0.76337111 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 0.75854001 |
| 88 | MP0005670_abnormal_white_adipose | 0.73168128 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 0.73029803 |
| 90 | MP0009053_abnormal_anal_canal | 0.72096113 |
| 91 | MP0002876_abnormal_thyroid_physiology | 0.71732937 |
| 92 | MP0003941_abnormal_skin_development | 0.70805659 |
| 93 | MP0004130_abnormal_muscle_cell | 0.70439373 |
| 94 | MP0002971_abnormal_brown_adipose | 0.70232774 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.70199079 |
| 96 | MP0000538_abnormal_urinary_bladder | 0.68656660 |
| 97 | MP0001661_extended_life_span | 0.68468408 |
| 98 | MP0005334_abnormal_fat_pad | 0.68318310 |
| 99 | MP0000428_abnormal_craniofacial_morphol | 0.67978770 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.65941345 |
| 101 | MP0005390_skeleton_phenotype | 0.65038179 |
| 102 | MP0004858_abnormal_nervous_system | 0.64721089 |
| 103 | MP0000049_abnormal_middle_ear | 0.64291532 |
| 104 | MP0003690_abnormal_glial_cell | 0.63613181 |
| 105 | MP0004510_myositis | 0.63159134 |
| 106 | MP0000639_abnormal_adrenal_gland | 0.62710447 |
| 107 | MP0005266_abnormal_metabolism | 0.62246792 |
| 108 | MP0005535_abnormal_body_temperature | 0.62058607 |
| 109 | MP0006138_congestive_heart_failure | 0.61940747 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.59588905 |
| 111 | MP0010352_gastrointestinal_tract_polyps | 0.59221595 |
| 112 | MP0002933_joint_inflammation | 0.59044454 |
| 113 | MP0000163_abnormal_cartilage_morphology | 0.58953613 |
| 114 | MP0001614_abnormal_blood_vessel | 0.58783044 |
| 115 | MP0002177_abnormal_outer_ear | 0.57677161 |
| 116 | MP0001756_abnormal_urination | 0.57588576 |
| 117 | MP0003329_amyloid_beta_deposits | 0.57408731 |
| 118 | MP0000750_abnormal_muscle_regeneration | 0.57308407 |
| 119 | MP0005464_abnormal_platelet_physiology | 0.55703371 |
| 120 | MP0010386_abnormal_urinary_bladder | 0.54808022 |
| 121 | MP0005448_abnormal_energy_balance | 0.54708535 |
| 122 | MP0005165_increased_susceptibility_to | 0.54332505 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.52666238 |
| 124 | MP0005395_other_phenotype | 0.49487175 |
| 125 | MP0002837_dystrophic_cardiac_calcinosis | 0.47263824 |
| 126 | MP0002928_abnormal_bile_duct | 0.46161868 |
| 127 | MP0003718_maternal_effect | 0.45287457 |
| 128 | MP0005248_abnormal_Harderian_gland | 0.44730239 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.44290205 |
| 130 | MP0008874_decreased_physiological_sensi | 0.43813146 |
| 131 | MP0008873_increased_physiological_sensi | 0.42852836 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.42638385 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.42594896 |
| 134 | MP0003436_decreased_susceptibility_to | 0.40234564 |
| 135 | MP0002822_catalepsy | 0.40176286 |
| 136 | MP0003953_abnormal_hormone_level | 0.38607884 |
| 137 | MP0003075_altered_response_to | 0.38230407 |
| 138 | MP0009672_abnormal_birth_weight | 0.37982865 |
| 139 | MP0003724_increased_susceptibility_to | 0.37958000 |
| 140 | MP0001243_abnormal_dermal_layer | 0.36828390 |
| 141 | MP0009384_cardiac_valve_regurgitation | 0.35987170 |
| 142 | MP0004381_abnormal_hair_follicle | 0.35006623 |
| 143 | MP0005166_decreased_susceptibility_to | 0.34741246 |
| 144 | MP0004883_abnormal_blood_vessel | 0.34519280 |
| 145 | MP0008872_abnormal_physiological_respon | 0.34167253 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.33969485 |
| 147 | MP0000579_abnormal_nail_morphology | 0.33355259 |
| 148 | MP0000249_abnormal_blood_vessel | 0.33352857 |
| 149 | MP0002168_other_aberrant_phenotype | 0.32366580 |
| 150 | MP0009115_abnormal_fat_cell | 0.31801738 |
| 151 | MP0002796_impaired_skin_barrier | 0.30604226 |
| 152 | MP0000230_abnormal_systemic_arterial | 0.30278356 |
| 153 | MP0006082_CNS_inflammation | 0.29090496 |
| 154 | MP0002970_abnormal_white_adipose | 0.29029986 |
| 155 | MP0002060_abnormal_skin_morphology | 0.28972546 |
| 156 | MP0001853_heart_inflammation | 0.27671297 |
| 157 | MP0005164_abnormal_response_to | 0.26817206 |
| 158 | MP0001845_abnormal_inflammatory_respons | 0.26066593 |
| 159 | MP0002132_abnormal_respiratory_system | 0.26014103 |
| 160 | MP0001881_abnormal_mammary_gland | 0.25791090 |
| 161 | MP0000427_abnormal_hair_cycle | 0.25459111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.65538697 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.40942746 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.32007420 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.73168053 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.63281888 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.60443688 |
| 7 | Xanthomatosis (HP:0000991) | 6.33291786 |
| 8 | Premature rupture of membranes (HP:0001788) | 5.74232137 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.57018804 |
| 10 | Complement deficiency (HP:0004431) | 5.36720892 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.91323044 |
| 12 | Joint hemorrhage (HP:0005261) | 4.90423663 |
| 13 | Protrusio acetabuli (HP:0003179) | 4.68360720 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.63889747 |
| 15 | Hyperammonemia (HP:0001987) | 4.59551158 |
| 16 | Epidermoid cyst (HP:0200040) | 4.56635761 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.49268364 |
| 18 | Aortic dissection (HP:0002647) | 4.39924647 |
| 19 | Hyperglycinemia (HP:0002154) | 4.38860463 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.29554865 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24735204 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.23952353 |
| 23 | Ketosis (HP:0001946) | 4.21639333 |
| 24 | Vascular tortuosity (HP:0004948) | 4.16605363 |
| 25 | Fat malabsorption (HP:0002630) | 4.14827446 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13204979 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11475326 |
| 28 | Arterial tortuosity (HP:0005116) | 4.00203561 |
| 29 | Aortic aneurysm (HP:0004942) | 3.98189883 |
| 30 | Abnormality of complement system (HP:0005339) | 3.92513402 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.87105463 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.86213300 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.86213300 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.85479331 |
| 35 | Hyperglycinuria (HP:0003108) | 3.82444943 |
| 36 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.81045776 |
| 37 | Conjugated hyperbilirubinemia (HP:0002908) | 3.75912730 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.71258418 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.43143874 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30397449 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.26883852 |
| 42 | Soft skin (HP:0000977) | 3.13708824 |
| 43 | Spontaneous abortion (HP:0005268) | 3.13378223 |
| 44 | Delayed CNS myelination (HP:0002188) | 3.12534273 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 3.12146500 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 3.08988097 |
| 47 | Peritonitis (HP:0002586) | 3.08301686 |
| 48 | Steatorrhea (HP:0002570) | 3.05888644 |
| 49 | Ankle contracture (HP:0006466) | 3.02701866 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 3.02681307 |
| 51 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01415473 |
| 52 | Follicular hyperkeratosis (HP:0007502) | 2.97926763 |
| 53 | Ketoacidosis (HP:0001993) | 2.97232964 |
| 54 | Bladder diverticulum (HP:0000015) | 2.95353013 |
| 55 | Type 1 muscle fiber predominance (HP:0003803) | 2.94615493 |
| 56 | Myocardial infarction (HP:0001658) | 2.93419085 |
| 57 | Skin nodule (HP:0200036) | 2.85305362 |
| 58 | Acanthocytosis (HP:0001927) | 2.82668493 |
| 59 | Long toe (HP:0010511) | 2.79405881 |
| 60 | Atrophic scars (HP:0001075) | 2.77012372 |
| 61 | Metabolic acidosis (HP:0001942) | 2.71681055 |
| 62 | Abnormal delivery (HP:0001787) | 2.67421497 |
| 63 | Cerebral aneurysm (HP:0004944) | 2.65789925 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.64211328 |
| 65 | Abnormality of purine metabolism (HP:0004352) | 2.61600321 |
| 66 | Abnormality of dentin (HP:0010299) | 2.58283720 |
| 67 | Hydroureter (HP:0000072) | 2.55388798 |
| 68 | Vascular calcification (HP:0004934) | 2.55127401 |
| 69 | Glomerulonephritis (HP:0000099) | 2.54545099 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.53901930 |
| 71 | Spastic diplegia (HP:0001264) | 2.53680884 |
| 72 | Lethargy (HP:0001254) | 2.52866657 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51426650 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.51426650 |
| 75 | Hypoglycemic seizures (HP:0002173) | 2.49133831 |
| 76 | Cholelithiasis (HP:0001081) | 2.48146878 |
| 77 | Blue sclerae (HP:0000592) | 2.47769044 |
| 78 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.45041923 |
| 79 | Single umbilical artery (HP:0001195) | 2.45041923 |
| 80 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.45041923 |
| 81 | Fragile skin (HP:0001030) | 2.44383493 |
| 82 | Ulnar bowing (HP:0003031) | 2.43791275 |
| 83 | Mitral stenosis (HP:0001718) | 2.42951612 |
| 84 | Vertebral compression fractures (HP:0002953) | 2.39326876 |
| 85 | Abnormal gallbladder physiology (HP:0012438) | 2.35366039 |
| 86 | Cholecystitis (HP:0001082) | 2.35366039 |
| 87 | Gout (HP:0001997) | 2.34449258 |
| 88 | Cerebral edema (HP:0002181) | 2.34250781 |
| 89 | Esophageal varix (HP:0002040) | 2.31158855 |
| 90 | Neonatal onset (HP:0003623) | 2.30820649 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.30662923 |
| 92 | Irritability (HP:0000737) | 2.29580369 |
| 93 | Gingival bleeding (HP:0000225) | 2.29043830 |
| 94 | Malnutrition (HP:0004395) | 2.28620166 |
| 95 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28038557 |
| 96 | Wormian bones (HP:0002645) | 2.27585605 |
| 97 | Amyloidosis (HP:0011034) | 2.26816569 |
| 98 | Aneurysm (HP:0002617) | 2.25703153 |
| 99 | Poikilocytosis (HP:0004447) | 2.25060724 |
| 100 | Intestinal atresia (HP:0011100) | 2.24228657 |
| 101 | Broad metatarsal (HP:0001783) | 2.21936213 |
| 102 | Dilatation of the ascending aorta (HP:0005111) | 2.21715182 |
| 103 | Menorrhagia (HP:0000132) | 2.21690644 |
| 104 | Spinal rigidity (HP:0003306) | 2.21447748 |
| 105 | Thrombophlebitis (HP:0004418) | 2.16229119 |
| 106 | Facial shape deformation (HP:0011334) | 2.15743647 |
| 107 | Potter facies (HP:0002009) | 2.15743647 |
| 108 | Sensorimotor neuropathy (HP:0007141) | 2.11069484 |
| 109 | Pancreatitis (HP:0001733) | 2.11042714 |
| 110 | Enlarged kidneys (HP:0000105) | 2.10676507 |
| 111 | Abnormality of the Achilles tendon (HP:0005109) | 2.10310010 |
| 112 | Late onset (HP:0003584) | 2.05699387 |
| 113 | Abnormality of the gallbladder (HP:0005264) | 2.05199598 |
| 114 | Mitral valve prolapse (HP:0001634) | 2.04833345 |
| 115 | Spontaneous hematomas (HP:0007420) | 2.04027827 |
| 116 | Brushfield spots (HP:0001088) | 2.04019145 |
| 117 | Hemorrhage of the eye (HP:0011885) | 2.01829947 |
| 118 | Elbow flexion contracture (HP:0002987) | 2.01365202 |
| 119 | Slender build (HP:0001533) | 2.01309033 |
| 120 | Vomiting (HP:0002013) | 2.00949562 |
| 121 | Camptodactyly of toe (HP:0001836) | 2.00675680 |
| 122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.00245240 |
| 123 | Opisthotonus (HP:0002179) | 1.97903534 |
| 124 | Generalized aminoaciduria (HP:0002909) | 1.97231728 |
| 125 | Wide anterior fontanel (HP:0000260) | 1.96648560 |
| 126 | Cervical subluxation (HP:0003308) | 1.96030161 |
| 127 | Increased mean platelet volume (HP:0011877) | 1.92618800 |
| 128 | Impaired platelet aggregation (HP:0003540) | 1.91916186 |
| 129 | Abnormal platelet function (HP:0011869) | 1.91916186 |
| 130 | Rickets (HP:0002748) | 1.90031460 |
| 131 | Abnormal cartilage morphology (HP:0002763) | 1.89870315 |
| 132 | Abnormality of iron homeostasis (HP:0011031) | 1.88931074 |
| 133 | Hypoventilation (HP:0002791) | 1.87218507 |
| 134 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86092131 |
| 135 | Increased corneal curvature (HP:0100692) | 1.84305326 |
| 136 | Keratoconus (HP:0000563) | 1.84305326 |
| 137 | Hydroxyprolinuria (HP:0003080) | 1.83628828 |
| 138 | Abnormality of proline metabolism (HP:0010907) | 1.83628828 |
| 139 | Renal cortical cysts (HP:0000803) | 1.82773483 |
| 140 | Conjunctival telangiectasia (HP:0000524) | 1.81608937 |
| 141 | Reticulocytosis (HP:0001923) | 1.81125694 |
| 142 | Elevated alkaline phosphatase (HP:0003155) | 1.80795433 |
| 143 | Hypophosphatemic rickets (HP:0004912) | 1.80554777 |
| 144 | Nephritis (HP:0000123) | 1.80123403 |
| 145 | Elevated hepatic transaminases (HP:0002910) | 1.79856234 |
| 146 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79122549 |
| 147 | Genu recurvatum (HP:0002816) | 1.77498404 |
| 148 | Alkalosis (HP:0001948) | 1.77446978 |
| 149 | Neonatal death (HP:0003811) | 1.76027925 |
| 150 | Abnormality of the umbilical cord (HP:0010881) | 1.76023246 |
| 151 | Abnormality of vitamin metabolism (HP:0100508) | 1.74164985 |
| 152 | Wrist flexion contracture (HP:0001239) | 1.73496732 |
| 153 | Status epilepticus (HP:0002133) | 1.73305401 |
| 154 | Hyperextensible skin (HP:0000974) | 1.72847093 |
| 155 | Biconcave vertebral bodies (HP:0004586) | 1.72807922 |
| 156 | Abnormality of the pulmonary veins (HP:0011718) | 1.71215835 |
| 157 | Persistence of primary teeth (HP:0006335) | 1.71191296 |
| 158 | Bowel diverticulosis (HP:0005222) | 1.70057851 |
| 159 | Joint laxity (HP:0001388) | 1.69475735 |
| 160 | Ovoid vertebral bodies (HP:0003300) | 1.68859613 |
| 161 | Spondylolisthesis (HP:0003302) | 1.67450028 |
| 162 | Achilles tendon contracture (HP:0001771) | 1.66229204 |
| 163 | Bowed forearm bones (HP:0003956) | 1.64504839 |
| 164 | Bowing of the arm (HP:0006488) | 1.64504839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.98459283 |
| 2 | MYLK | 5.79777380 |
| 3 | SIK1 | 4.79540974 |
| 4 | FGFR4 | 4.44738303 |
| 5 | ERN1 | 4.10062621 |
| 6 | GRK7 | 3.64271832 |
| 7 | TAOK3 | 2.94865026 |
| 8 | INSRR | 2.93749096 |
| 9 | NTRK1 | 2.85719247 |
| 10 | ERBB4 | 2.80690162 |
| 11 | PKN2 | 2.69579916 |
| 12 | MAP2K4 | 2.33268814 |
| 13 | LIMK1 | 2.27798342 |
| 14 | MST1R | 2.24312490 |
| 15 | FLT3 | 2.10359645 |
| 16 | PAK2 | 2.09975911 |
| 17 | EPHB2 | 2.07986337 |
| 18 | TRIB3 | 2.01355595 |
| 19 | PIK3CG | 1.98458221 |
| 20 | LATS1 | 1.94946092 |
| 21 | MAPK11 | 1.90941125 |
| 22 | TTN | 1.84767572 |
| 23 | PRKD2 | 1.74700646 |
| 24 | PAK4 | 1.72348644 |
| 25 | TYK2 | 1.70418286 |
| 26 | AKT3 | 1.70154527 |
| 27 | PTK6 | 1.58804960 |
| 28 | FRK | 1.57458013 |
| 29 | FGFR2 | 1.55143942 |
| 30 | DAPK2 | 1.54093799 |
| 31 | ABL2 | 1.50669589 |
| 32 | ADRBK1 | 1.50636173 |
| 33 | NEK9 | 1.43750316 |
| 34 | KDR | 1.43544227 |
| 35 | TLK1 | 1.40430683 |
| 36 | MOS | 1.35169030 |
| 37 | JAK2 | 1.21551805 |
| 38 | TRPM7 | 1.19553041 |
| 39 | DDR2 | 1.19297465 |
| 40 | MAP3K10 | 1.18838660 |
| 41 | MAP3K7 | 1.18010756 |
| 42 | TESK1 | 1.14842590 |
| 43 | ROCK1 | 1.12797268 |
| 44 | PRKAA2 | 1.12794249 |
| 45 | CDC42BPA | 1.10660463 |
| 46 | ERBB2 | 1.04552053 |
| 47 | STK38 | 1.04304622 |
| 48 | MAP2K3 | 1.03556108 |
| 49 | GRK5 | 1.03412566 |
| 50 | PTK2B | 1.02226473 |
| 51 | GRK6 | 1.01829339 |
| 52 | JAK1 | 1.01757477 |
| 53 | PDGFRB | 1.00257605 |
| 54 | MET | 0.99000993 |
| 55 | MAPK4 | 0.98062651 |
| 56 | PINK1 | 0.97950572 |
| 57 | ROCK2 | 0.96168454 |
| 58 | TBK1 | 0.92116045 |
| 59 | ADRBK2 | 0.90336119 |
| 60 | PRKCZ | 0.89616817 |
| 61 | CDK6 | 0.88613537 |
| 62 | MAP3K14 | 0.88033398 |
| 63 | EPHA3 | 0.85630750 |
| 64 | DAPK3 | 0.85509502 |
| 65 | STK38L | 0.84404487 |
| 66 | PIM2 | 0.84396119 |
| 67 | PRKG2 | 0.84158016 |
| 68 | RIPK1 | 0.83353117 |
| 69 | PLK2 | 0.82253831 |
| 70 | EPHB1 | 0.81340415 |
| 71 | CAMK1D | 0.80745665 |
| 72 | ZAP70 | 0.79556930 |
| 73 | MAP3K3 | 0.79037803 |
| 74 | TIE1 | 0.78355286 |
| 75 | PRKACG | 0.76230696 |
| 76 | MAPK12 | 0.74679515 |
| 77 | DYRK1B | 0.69194984 |
| 78 | CSK | 0.68992034 |
| 79 | SCYL2 | 0.68221169 |
| 80 | PRKAA1 | 0.67934768 |
| 81 | TGFBR2 | 0.67494347 |
| 82 | MAP3K11 | 0.66926975 |
| 83 | GSK3A | 0.66256473 |
| 84 | EPHA2 | 0.64397387 |
| 85 | RPS6KA2 | 0.63699061 |
| 86 | CAMK2G | 0.63585068 |
| 87 | MELK | 0.63422409 |
| 88 | SGK3 | 0.63345907 |
| 89 | PAK6 | 0.63202905 |
| 90 | PTK2 | 0.62948756 |
| 91 | CSF1R | 0.62349318 |
| 92 | DMPK | 0.61755611 |
| 93 | FGFR3 | 0.61053904 |
| 94 | TGFBR1 | 0.55697913 |
| 95 | MAPK15 | 0.55526243 |
| 96 | ARAF | 0.54957829 |
| 97 | MAPK7 | 0.53659855 |
| 98 | PRKD1 | 0.53341486 |
| 99 | MAP2K6 | 0.52426409 |
| 100 | CAMKK2 | 0.52171606 |
| 101 | RET | 0.51374520 |
| 102 | PDPK1 | 0.49819569 |
| 103 | PRKCQ | 0.49587739 |
| 104 | FER | 0.48392097 |
| 105 | CSNK1G1 | 0.47039151 |
| 106 | IGF1R | 0.47004367 |
| 107 | MAP2K1 | 0.44943459 |
| 108 | SGK2 | 0.44450641 |
| 109 | CDK4 | 0.43397952 |
| 110 | STK10 | 0.42576998 |
| 111 | MTOR | 0.41007032 |
| 112 | IKBKE | 0.40900171 |
| 113 | GRK1 | 0.40743857 |
| 114 | EPHA4 | 0.39849801 |
| 115 | ERBB3 | 0.39642850 |
| 116 | PDGFRA | 0.39508734 |
| 117 | MAP3K5 | 0.39202232 |
| 118 | ILK | 0.37778879 |
| 119 | PRKCG | 0.36816541 |
| 120 | PBK | 0.36176415 |
| 121 | PRKCE | 0.34879386 |
| 122 | PNCK | 0.34844113 |
| 123 | LATS2 | 0.34778238 |
| 124 | TAOK2 | 0.34222193 |
| 125 | IRAK3 | 0.33929703 |
| 126 | MAP3K12 | 0.33890978 |
| 127 | ICK | 0.33748427 |
| 128 | PRPF4B | 0.33572260 |
| 129 | PIK3CA | 0.32192123 |
| 130 | PDK1 | 0.31881644 |
| 131 | EGFR | 0.31370820 |
| 132 | CHUK | 0.30619250 |
| 133 | PKN1 | 0.30557840 |
| 134 | MAP3K13 | 0.30236616 |
| 135 | SRC | 0.29867669 |
| 136 | CAMK1G | 0.28823599 |
| 137 | SGK223 | 0.28758669 |
| 138 | SGK494 | 0.28758669 |
| 139 | STK3 | 0.27823651 |
| 140 | KSR2 | 0.27758815 |
| 141 | CAMK4 | 0.27035453 |
| 142 | MAP3K6 | 0.27011849 |
| 143 | PAK3 | 0.26121719 |
| 144 | CSNK1G2 | 0.25533620 |
| 145 | PAK1 | 0.25489291 |
| 146 | BMX | 0.24726939 |
| 147 | FGFR1 | 0.24246114 |
| 148 | PRKCA | 0.24156440 |
| 149 | ABL1 | 0.22095275 |
| 150 | CSNK1G3 | 0.20726450 |
| 151 | PDK3 | 0.18970486 |
| 152 | INSR | 0.15638480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.49682954 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.78687914 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41002593 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37352185 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05417668 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.82364663 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73978637 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67063748 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63153128 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53025078 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49431361 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36666208 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25851146 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16035792 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12427540 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.04706486 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95876097 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94789096 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92581121 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92453557 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87993249 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85852916 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82251185 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80247110 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78710304 |
| 26 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.74587596 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.73633252 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71697198 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70792681 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68875060 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66176855 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65154377 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59297931 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55868338 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.51019233 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47243712 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46781321 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42232136 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34379599 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34259995 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33176321 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29286445 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28191078 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.21509553 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18721071 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18532065 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17813516 |
| 48 | Focal adhesion_Homo sapiens_hsa04510 | 1.17143680 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14638948 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12055843 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03573933 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97469385 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96525093 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95437960 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94353888 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94306675 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91157950 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88252712 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87918297 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87368800 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83159901 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83117839 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.82876174 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77675201 |
| 65 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.76987993 |
| 66 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70279265 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69255813 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68156431 |
| 69 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66390769 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66134020 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.65294522 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65116937 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59912868 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56645263 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56433740 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54460310 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54231272 |
| 78 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50328509 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45814788 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45316515 |
| 81 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45042412 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44209475 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37208379 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.33417339 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.29646493 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29142958 |
| 87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.28622447 |
| 88 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.28027601 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26653436 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24917985 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.24294651 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23819041 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22717016 |
| 94 | Melanoma_Homo sapiens_hsa05218 | 0.21240757 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21012464 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20838783 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20071641 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.17189418 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13457631 |
| 100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.12224452 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10166709 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.08405658 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.07549067 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.07241611 |
| 105 | Shigellosis_Homo sapiens_hsa05131 | 0.06985632 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03115896 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2363597 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | -0.2312200 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2256460 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2254362 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | -0.2176778 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1902762 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1855746 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | -0.1847933 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1846663 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1833948 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1779720 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1774665 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1757565 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1526464 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1400700 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1038129 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0918827 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0877807 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0777959 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0605926 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0555840 |

